Credit: Pixabay/CC0 Public Domain Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and….
In patients who’ve had a large core stroke, the benefits of thrombectomy can continue to increase out to 1-year follow-up, new results from the SELECT2 trial showed. Other new data….
